BridgeMD
New treatment option for Cerebral Palsy
Official title Multicenter Trial of Proximal Femoral Guided Growth in Children With CP and Hips at Risk of Dislocation (GGSH-MC)
ClinicalTrials.gov ID: NCT06956729
What this study is testing
- What it's testing
- The Guided Growth in Spastic Hip Multicenter Study (GGSH-MC) is a prospective, multicenter, randomized controlled trial that aims to evaluate the mid-term outcomes of Proximal Femoral Guided Growth (PFGG) in children with spastic cerebral palsy (CP) and hips at risk of dislocation (HRD). Hip dislocation is a common and severe complication in children with CP, especially those who are non-ambulatory, with a reported risk of 70-90%.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 8
You may be able to join if
- Patients aged 3 to 8 years.
- Diagnosis of predominantly spastic cerebral palsy (CP).
- Any functional level according to the GMFCS.
- Hips at risk of dislocation (HRD), unilateral or bilateral, defined by a migration percentage (MP) between 30% and 60%.
You likely can't join if
- Children with predominantly hypotonic or dystonic types of CP.
- Children with neuromuscular conditions other than CP.
- Children with high surgical/anesthetic risk.
- Documented history of reconstructive or palliative hip surgery.
The study team makes the final eligibility decision.
Where it's taking place
- A Coruña, A Coruña, Spain
- Almería, Andalusia, Spain
- Seville, Andalusia, Spain
- Palma, Balearic Islands, Spain
- Salamanca, Castille and León, Spain
- Barcelona, Catalonia, Spain
- Donostia / San Sebastian, Gipuzkoa, Spain
- Madrid, Madrid, Spain
- Pamplona, Navarre, Spain
- Oviedo, Principality of Asturias, Spain
- Santa Cruz de Tenerife, Santa Cruz de Tenerife, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years to 8 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include A Coruña, A Coruña, Spain; Almería, Andalusia, Spain; Seville, Andalusia, Spain; Palma, Balearic Islands, Spain; Salamanca, Castille and León, Spain; Barcelona, Catalonia, Spain and 5 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.